Table 1

’ Est.

Pt. No.

& sex

Age

1979

thyroid
dose

(rads)

(cont'd)

Thyroid Nodularities
Age at

detection

Surgery

Hypofunction

Diagnosis

TSH (UU/d1)

(c) Rongelap exposed at age >18
18 F

64 F

4M

45

55

63

335

335

335

78 F
71 °F

62
52

335
335

66 F

55

335

34 F

70

335

34

4l

Cleve.

Bost.

'69

'65

Papillary Ca

Papillary Ca

6.0,

7.0

6.6, 8.8
6.5, 7.0
55

6.3, 8.3

Cleve.

'79

Adenomatous nod.

Cleve.
Cleve.

'72
‘81

Adenomatous nod.
Occult Pap. Ca
and adenomatous nod.

'74

Adenoma

(d) Ailingnae exposed at age <10
8 F
53 F

26
33

450
320

18
28

(e) Ailingnae exposed at age 10-18:

NONE

(f) Ailingnae exposed at age >18
51 F

50

45 F

57

41 M

135

135

59 F

69

--

135

16 M

64

135

135

45

Cleve.

51

Cleve.

53

Bost.

'73

'66

Adenomatous nod.

Nodule

Adenomatous nod.
(died '68, age 54)

6.4, 6.5

(g) Utirik exposed at age <1l0
2160 F

29

80

25

2154 F

31

75

28

2147 F

26

90

25

Cleve.

‘75

Papillary Ca
Nodule

Cleve.

‘79

2239 F

28

80

28

Cleve.

2132 F

277

80

27

Cleve.

‘81
'81

'76
'69

reduced '79
Adenomatous nod.
"

"

"

"

(h) Utirik exposed at age 10-18
2150 M
2229 F

37
43

54
31

33
32

Cleve.
Cleve.

2236 M

36

55

34

Hono.

'78

- 126 -

Adenoma
Papillary Ca

vs. atypical adenoma

Adenoma

Select target paragraph3